Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Junya Iwasaki · SciRah

Researcher profile · Semantic Scholar

Junya Iwasaki

Share profile

Junya Iwasaki — researcher profile on SciRah

h-index: 7
Works: 9
Citations: 527

Most-cited papers

Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
S. Noguchi, Y. Yasui, Junya Iwasaki, Minami Kumazaki +3 more
2013Cancer Letters143 citations
Semantic Scholar
Anti-cancer effects of naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells.
Minami Kumazaki, S. Noguchi, Y. Yasui, Junya Iwasaki +3 more
2013Journal of Nutritional Biochemistry129 citations
Semantic Scholar
Anti-oncogenic MicroRNA-203 Induces Senescence by Targeting E2F3 Protein in Human Melanoma Cells
S. Noguchi, Takashi Mori, Yusami Otsuka, N. Yamada +5 more
2012Journal of Biological Chemistry101 citations Open access
Semantic Scholar
socs7, a target gene of microRNA-145, regulates interferon-β induction through STAT3 nuclear translocation in bladder cancer cells
S. Noguchi, N. Yamada, Minami Kumazaki, Y. Yasui +3 more
2013Cell Death and Disease65 citations Open access
Semantic Scholar
Chemically modified synthetic microRNA-205 inhibits the growth of melanoma cells in vitro and in vivo.
S. Noguchi, Junya Iwasaki, Minami Kumazaki, Takashi Mori +7 more
2013Molecular Therapy60 citations Open access
Semantic Scholar
Schlafen11 Expression Is Associated With the Antitumor Activity of Trabectedin in Human Sarcoma Cell Lines
Junya Iwasaki, Toshiharu Komori, F. Nakagawa, H. Nagase +3 more
2019Anticancer Research22 citations Open access
Semantic Scholar
TAS0612, a novel RSK, AKT, and S6K inhibitor, exhibits antitumor effects in preclinical tumor models.
Koji Ichikawa, Satoshi Ito, Emi Kato, Naomi Abe +9 more
2023Molecular Cancer Therapeutics7 citations
Semantic Scholar
Abstract 661: Synergistic antitumor activity of futibatinib, an FGFR1-4 inhibitor, and TAS-117, a selective AKT inhibitor, inFGFR-deregulated cancer models
Junya Iwasaki, T. Kuramoto, Toshiharu Komori, H. Saito +1 more
2020Experimental and Molecular Therapeutics1 citations
Semantic Scholar
Human Melanoma Cells Senescence by Targeting E 2 F 3 Protein in Anti-oncogenic MicroRNA-203 Induces Cell
S. Noguchi, Takashi Mori, Yusami Otsuka, N. Yamada +5 more
20120 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Noguchi×6
Invite
S. Noguchi — researcher profile on SciRah
Minami Kumazaki×6
Invite
Minami Kumazaki — researcher profile on SciRah
N. Yamada×6
Invite
N. Yamada — researcher profile on SciRah
Y. Akao×6
Invite
Y. Akao — researcher profile on SciRah

×5

Invite

Y. Yasui — researcher profile on SciRah

Takashi Mori×3

Invite

Takashi Mori — researcher profile on SciRah

Invite

K. Maruo — researcher profile on SciRah

Invite

S. Naito — researcher profile on SciRah

Yusami Otsuka×2

Invite

Yusami Otsuka — researcher profile on SciRah

Toshiharu Komori×2

Invite

Toshiharu Komori — researcher profile on SciRah

Haruka Shinohara×1

Invite

Haruka Shinohara — researcher profile on SciRah

Invite

H. Sakai — researcher profile on SciRah